|
QT-219CX Clinical Trials
1 actively recruiting trial
Pipeline
Early 1: 1
Top Sponsors
- The Children's Hospital of Zhejiang University School of Medicine1
Indications
- ANCA Associated Systemic Vasculitis1
- Multi-Drug Resistant Nephrotic Syndrome1
- Systemic Lupus Erthematosus (SLE)1
- IgA Nephropathy (IgAN)1
- Systemic Sclerosis (SSc)1
Other1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.